Analysts who follow BioCardia Inc (BCDA) on average expect it to rise 852.38% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns the stock an Analyst Ranking of 25, which means it ranks higher than 25 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating BCDA a Buy today. Find out what this means to you and get the rest of the rankings on BCDA!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With BioCardia Inc Stock Today?
BioCardia Inc (BCDA) stock is unchanged -0.98% while the S&P 500 has gained 0.02% as of 1:12 PM on Thursday, Mar 28. BCDA is flat $0.00 from the previous closing price of $0.42 on volume of 225,370 shares. Over the past year the S&P 500 is up 30.33% while BCDA has fallen -79.71%. BCDA lost -$0.63 per share the over the last 12 months.
Click Here to get the full Stock Report for BioCardia Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
